US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 7.830
- -0.300-3.69%
Close Nov 1 16:00 ET
152.93MMarket Cap-3033P/E (TTM)
8.400High7.280Low115.06KVolume8.000Open8.130Pre Close900.29KTurnover4.11%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High-1.34P/B21.92MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM13.78%Amplitude5.510Historical Low7.824Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Actuate Therapeutics Stock Forum
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...
No comment yet